TETRAPHASE PHARMACEUTICALS INC Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 105 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-03-19: Reporting owner FMR LLC; Form 3; Security Series C Convertible Preferred Stock; Transaction Holding.
- 2013-03-19: Reporting owner FMR LLC; Form 3; Security Series A-1 Convertible Preferred Stock; Transaction Holding.
- 2013-03-19: Reporting owner FMR LLC; Form 3; Security Series A-2 Convertible Preferred Stock; Transaction Holding.
- 2013-03-19: Reporting owner FMR LLC; Form 3; Security Series B Convertible Preferred Stock; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-03-19 holding as of filing | FMR LLC | 3 | Series C Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Limited Partnership | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | FMR LLC | 3 | Series A-1 Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Principals Limited Partnership | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | FMR LLC | 3 | Series A-2 Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Principals Limited Partnership | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | FMR LLC | 3 | Series B Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Principals Limited Partnership | Holding | no price filed | 2013-03-19 | ||
| 2013-03-19 holding as of filing | FMR LLC | 3 | Series C Convertible Preferred Stock Derivative · Indirect · by Beacon Bioventures Principals Limited Partnership | Holding | no price filed | 2013-03-19 |